Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea

    NEXT STORY
    Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients
    PREV STORY
    Teleflex to Present at the 31st Annual Piper Jaffray Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Amicus Therapeutics Announces Presentations and Posters at 15th Annual WORLDSymposium™ 2019

    CRANBURY, N.J., Jan. 18, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global ...

    author_avatar
    NASDAQ Market News

    Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART27.13

    author_avatar
    NASDAQ Market News

    Selecta Biosciences to Present at the Jefferies Global Healthcare Conference on June 7, 2017

    WATERTOWN, Mass., May 31, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage ...

    author_avatar
    NASDAQ Market News